BN Business News
Add your company to Business Communicator →

Business · 23/09/2003Updated: 10/17/2026 · 1 min read

FDA Approves Supplemental ANADA for Pyrantel Pamoate Suspension

Summary

The Food and Drug Administration (FDA) is updating its regulations to reflect the approval of a supplemental application by Phoenix Scientific, Inc. for pyrantel pamoate suspension, which will allow for over-the-counter sales for treating internal parasites in horses and ponies through oral administration.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →